Receive updates from Psychedelics Today for free, starting right now.
We can deliver them by email, via your phone or you can read them from a personalised news page on follow.it.
This way you won't miss any new article from Psychedelics Today. Unsubscribe at any time.
Site title: Expert-informed media and education | Psychedelics Today
Is this your feed? Claim it!
DA approval of a psychedelic therapy now looks likely. VETS policy director Logan Davidson argues the harder fight starts the day after: REMS rules, insurance codes, VA formularies, and a workforce that was short before this therapy existed.
The post
Shannon Hughes and Dori Lewis train facilitators and run a licensed micro healing center in Colorado. They argue the state’s psilocybin program is pricing out the small practices it was built for, and propose three fixes.
The post Is It Wort...
Painter and Penn professor Jackie Tileston joins Joe to talk about nondual traditions, psychedelic integration, and clinical 5-MeO-DMT. They also dig into why most psychedelic art is a postcard from the trip, and what art can offer instead.
The post
The VA has chosen ten sites for the first approved psychedelic therapies but expects treating even 1,000 veterans in year one to be a challenge. Also this week: DEA comments closed on scheduling five tryptamines, including the compound behind a postpartum depression drug, and a DEA judge declined to reopen the cannabis rescheduling hearing.
The post
Timothy Leary became the scapegoat for decades of lost psychedelic research. That familiar story overlooks a much older system of prohibition. Joe Moore examines the claims we repeat—and what they obscure about political responsibility, religious freedom, and human flourishing.
The post